PrIME is a wholly owned subsidiary of NSP so that if it any moneys generated become part of NSP. However, stakeholders in PrIME become so on the condition that a fractionating facility be set up in Singapore. If 40 or 50% of PrIME is sold and funds in excess of setting up the facility are left over then they belong to NSP.
The benefit to NSP is that half of the profits from plasma sales go to us as well as all the sales of membrane that will be manufactured in Sydney.
The plan is set. The 6 months is already in all the calculated periods shown in the previous presentations, i.e. 6 months for set up; another 12 months for formal trial; but production into fridge storage can start before completion of trial (without sales in Singapore occurring). Actual dates depend on when the money is transferred to NSP.
Juke
MEM Price at posting:
7.0¢ Sentiment: LT Buy Disclosure: Held
